Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Skin Cancer
Skin cancer is the most common form of cancer in the United States. The two most common types are basal cell cancer and squamous cell cancer. They usually form on the head, face, neck, hands, and arms. Another type of skin cancer, melanoma, is more dangerous but less common.
Anyone can get skin cancer, but it is more common in people who :
- Spend a lot of time in the sun or have been sunburned
- Have light-colored skin, hair and eyes
- Have a family member with skin cancer
- Are over age 50
You should have your doctor check any suspicious skin markings and any changes in the way your skin looks. Treatment is more likely to work well when cancer is found early. If not treated, some types of skin cancer cells can spread to other tissues and organs. Treatments include surgery, radiation therapy, chemotherapy, photodynamic therapy (PDT), and biologic therapy. PDT uses a drug and a type of laser light to kill cancer cells. Biologic therapy boosts your body's own ability to fight cancer.
It sits within Cancers and Skin, Hair and Nails.
The lead U.S. institute for this subject is the National Cancer Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Skin Cancer
19,204 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)National Cancer Institute (NCI)
- Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryNational Cancer Institute (NCI)
- Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of RecurrenceNovartis Pharmaceuticals
- Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid TumorsNovartis Pharmaceuticals
- Tai Chi for Reducing Aromatase Inhibitor-Induced ArthralgiaThomas Jefferson University
Research already completed
- Tumor-Derived FGF19University of Central Florida
- Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryUniversity of Nebraska
- African Cancer Genome: GMDFox Chase Cancer Center
- Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung CancerHUYABIO International, LLC.
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- General Information about Skin CancerNational Cancer Institute
- Skin CancerMayo Foundation for Medical Education and Research
Diagnosis and Tests
- Skin BiopsyVisualDX
Treatments and Therapies
- Cryosurgery to Treat CancerNational Cancer Institute
- Drugs Approved for Skin CancerNational Cancer Institute
- ElectrodesiccationVisualDX
- Mohs Micrographic SurgeryVisualDX
Prevention and Risk Factors
- Reducing Risk for Skin CancerCenters for Disease Control and Prevention
- Skin Cancer PreventionNational Cancer Institute
Living With
- Living as a Basal or Squamous Cell Skin Cancer SurvivorAmerican Cancer Society
Related Issues
- Actinic CheilitisVisualDX
- Actinic Keratosis (Solar Keratosis)VisualDX
- Risks of Skin Cancer ScreeningNational Cancer Institute
- Skin Cancer in People with Darker SkinNational Cancer Institute
Genetics
- 9q22.3 microdeletion: MedlinePlus GeneticsNational Library of Medicine
- About Skin CancerNational Human Genome Research Institute
- Gorlin syndrome: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Advances in Melanoma and Other Skin Cancers ResearchNational Cancer Institute
- Melanoma of the Skin StatisticsCenters for Disease Control and Prevention
- Skin CancerAmerican Academy of Dermatology
Clinical Trials
- ClinicalTrials.gov: Basal Cell CarcinomaNational Institutes of Health
- ClinicalTrials.gov: Carcinoma, Merkel CellNational Institutes of Health
- ClinicalTrials.gov: Keratosis, ActinicNational Institutes of Health
- ClinicalTrials.gov: Skin NeoplasmsNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Skin Neoplasms. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Skin Cancer, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.